Auxier Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Auxier Asset Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-32,699	Closed	-$657K	–	154
2017 Q1	$657K	Hold	32,699	–	–	0.14%	108
2016 Q4	$510K	Sell	32,699 -17,857	-35%	-$241K	0.11%	112
2016 Q3	$660K	Hold	50,556	–	–	0.15%	100
2016 Q2	$346K	Hold	50,556	–	–	0.08%	118
2016 Q1	$478K	Buy	50,556 +32,699	+183%	+$264K	0.11%	107
2015 Q4	$180K	Buy	+17,857	New	+$236K	0.04%	141

Other funds holding ZYNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FTIOP

Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return

Auxier Asset Management's ZYNE Position: Q2 2017 in Review

Auxier Asset Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2017, closing a stake of 32,699 shares — an estimated $657K sold.

Auxier Asset Management first reported a position in ZYNE in Q4 2015 and held it in 6 quarters. The position peaked at $660K in Q3 2016. 66 funds tracked by Wall St. Rank hold ZYNE as of Q2 2017.

Auxier Asset Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2017 after selling out during the quarter.
Auxier Asset Management sold 32,699 Zynerba Pharmaceuticals, Inc shares in Q2 2017, an estimated $657K.
Auxier Asset Management first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2015 and held it in 6 quarters.
Auxier Asset Management's Zynerba Pharmaceuticals, Inc position peaked at $660K in Q3 2016.
66 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2017.

Based on Auxier Asset Management's 13F filing for Q2 2017, filed 16 Aug 2017.